Abeona Therapeutics ABEO
NASDAQ ABEO
$6.01 +0.08 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Abeona Therapeutics (ABEO) Net Margin Growth (3y) (2014 - 2026)

Analysis

Abeona Therapeutics (ABEO) Net Margin Growth (3y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -374.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -44.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 6,620.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -13,815.00
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 7,793.00
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 9,934.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - -5,319.00
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 31,387.00
10 Abeona Therapeutics 342.29 Mn 195.46 Mn 7.20 Mn 29,840.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29,840.00
Dec 31, 2025 978,933.00
Jun 30, 2025 3.19 Mn
Dec 31, 2020 510,440.00
Sep 30, 2020 233,151.00
Dec 31, 2018 -364,848.00
Sep 30, 2018 117,014.00
Jun 30, 2018 -297,736.00
Mar 31, 2018 -120,786.00
Dec 31, 2017 -23,718.00
Sep 30, 2017 -150,371.00
Jun 30, 2017 154,228.00
Mar 31, 2017 -205,943.00
Dec 31, 2016 1.09 Mn
Sep 30, 2016 -95,043.00
Jun 30, 2016 -331,790.00
Mar 31, 2016 -263,317.00
Dec 31, 2015 -291,576.00
Sep 30, 2015 -37,301.00
Jun 30, 2015 14,134.00